Insilico’s co-CEO hopes ‘we might have a chance to stop biological aging’ after promising results from its fibrosis drug trial

Fortune•Wed, Sep 9, 2026, 11:24 AM•2 min read

Drugmakers hope they can ease Asia's healthcare burden by tackling aging at its source, and one says it now has early evidence it's possible.

Source: [Fortune](https://fortune.com/2026/09/09/insilico-fibrosis-drug-trial-biological-aging/)

📰 Read Full Story

This is an aggregated headline summary. For the complete report, visit the original publisher.

More Headlines

TechnologyHacker News• 7m ago

2 points, 0 comments on Hacker News

BusinessSeeking Alpha• 9m ago

Developing story — details emerging. Check the source link for the latest updates.

SportsCBS Sports• 14m ago

Andrew Painter's rough outing raises questions, while Reid Detmers surges and Elly De La Cruz shows growth against lefties

AI & MLBBC News• 20m ago

It is the latest in a series of increasing warnings about the safety threat posed by artificial intelligence.

BusinessBusiness Insider• 27m ago

Publicis stunned Madison Avenue by winning PepsiCo's $1. 7 billion account while working for Coke — and pitching for more.

BusinessBusiness Insider• 27m ago

Jamie Drew is charged with looking beyond traditional fashion partnerships to areas beyond apparel to reach new audiences and create new businesses.